| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10746164 | Parkinsonism & Related Disorders | 2012 | 4 Pages |
Abstract
A previous history of nausea and hypotension, and older age should not dissuade a trial of apomorphine if clinically justified. A three day pre-treatment dose of trimethobenzamide, as recommended in the United States, does not reduce nausea.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
William G. Ondo, Christine Hunter, Joseph M. Ferrara, Giovanni Mostile,